Lamotrigine Tablets recall
Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA, For…
Why was Lamotrigine Tablets recalled?
Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #s 19P0437 & 19P0438, Exp. 09/30/2021.
- Product
- Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA, For…
- Recalling firm
- Jubilant Cadista Pharmaceuticals, Inc.
- Quantity
- 1,313,333 tablets
- Distribution
- TN
- Recall date
- June 3, 2020
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)